Paradromics Implants Connexus BCI in Patient With Motor Neuron Disease
Surgeons in Michigan have implanted Paradromics' Connexus brain-computer interface in a patient with motor neuron disease who had lost most of her ability to speak. Connexus records from individual neurons through 421 microelectrodes seated 1.5 millimeters into the motor cortex; the signals pass to a transceiver in the patient's chest, where AI converts them into text on a screen. Austin, Texas-based Paradromics received FDA approval in the fall of 2025 to begin the clinical trial.